Your search for ‘Bass, Berry & Sims’ returned 818 results

On November 17, 2025, the United States District Court for the Western District of Texas entered an order in Ecommerce Marketers Alliance, Inc. et al. v. State of Texas et al. explaining...

The SEC’s requested title for the shareholder proposal rulemaking, “Rescission of Rule 14a-8’s Federal Regulation of Shareholder Proposals,” signals a possible fundamental reconsideration of the federal shareholder proposal framework rather than incremental amendments.

Over the years, we have spoken repeatedly about the importance of a solid front line of cybersecurity defense – strong passwords. Robust passwords should be of a minimum number

In an attempt to address these risks, the U.S. government is imposing heightened cyber-security requirements on contractors, some of which are summarized below.

The Corporate Transparency Act (CTA) is a federal law that will require various types of businesses – such as corporations, limited liability companies, and limited partnerships operating in the United States...

California has raised the regulatory bar for anyone who invests in, manages or partners with healthcare entities in California. In October, California Gov.

On May 19, the Department of Justice (DOJ) announced the launch of the Civil Rights Fraud Initiative, which will use the federal False Claims Act (FCA) to pursue claims against recipients of federal funds that knowingly violate federal civil rights law.

Bass, Berry & Sims, Deloitte and Harris Williams proudly co-hosted the 14th annual Health Care Investors Conference (HCIC) on October 9 as an associated event of the Nashville Healthcare Sessions conference.

Bass, Berry & Sims hosted its second annual Healthcare Regulatory & Compliance Summit on March 4.

Angela Humphreys and Wyatt Ritchie examine the evolving healthcare private equity landscape, analyzing M&A trends, buyer psychology shifts, and regulatory developments that are reshaping deal structures heading into 2027. The session reveals how large-scale transactions are driving market activity while state-level regulations and federal enforcement create new timing and structural challenges for healthcare investors.

As the market for hemp-based products booms, many investors are grappling with (and consumers unaware of)

Understanding state PBM laws is essential for designing self-funded plans that maintain high-quality benefits and employee satisfaction.

Effective December 1, 2025, Tennessee will transition four services now subject to certificate of need (CON) requirements—Magnetic Resonance Imaging (MRI)...

On December 18, 2025, the U.S. Department of Health and Human Services Office of Inspector General published favorable Advisory Opinion 25-11, approving various discount structures, including bundled discounts and rebates contingent on achieving market share requirements, a biopharmaceutical manufacturer offers its customers on three vaccines.

Texas Attorney General secures $45 million settlement with Gilead Sciences over allegations that manufacturer patient support programs, including free nursing services and reimbursement assistance, functioned as illegal inducements to prescribers. This follows a similar $34 million AstraZeneca settlement, signaling heightened state scrutiny of pharmaceutical patient support programs under Texas anti-kickback laws.

On January 16, New Jersey joined the list of states with comprehensive consumer privacy statutes when Governor Phil Murphy signed into law Senate Bill 332 (the New Jersey Data Privacy Act or NJDPA).

Recent legislative and rulemaking activity at both the federal and state levels, along with changes in certain deal dynamics...